FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still have access.

Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal ...

Peter A. McCullough, a former cardiologist who promoted unproven treatments like ivermectin and hydroxychloroquine at the ...

The Food and Drug Administration is limiting the number of Americans who can get an annual COVID-19 vaccine shot. Dr. William ...

The FDA has granted full approval for Novavax's COVID-19 vaccine, but with restrictions. Discover the details now.

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

But the framework has perhaps created as much confusion as clarity. Broadly, the FDA said it will limit approval of Covid-19 ...

The FDA is getting rid of the Covid booster because . . . it's concerned about anti-vaxx sentiments. No, really.

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...

U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed informing the public about the risks of taking the jab—that is according to a ...

FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots ...